PROVECTUS BIOPHARMACEUTICALS, INC. 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Dec 22, 2015
Insider Transaction Report
Form 4
WACHTER ERIC PHD
DirectorVice President Pharmaceuticals
Transactions
- Exercise/Conversion
Common Stock
2015-12-21$1.02/sh+120,000$122,400→ 5,513,236 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-12-21−120,000→ 120,000 totalExercise: $1.02From: 2006-06-23Exp: 2016-06-23→ Common Stock (120,000 underlying)
Holdings
- 824,248(indirect: By 401(k))
Common Stock
- 4,867(indirect: By Trust)
Common Stock